IntelGenx Technologies Corp. (IGXT) Downgraded to Sell at ValuEngine

ValuEngine downgraded shares of IntelGenx Technologies Corp. (OTCMKTS:IGXT) from a hold rating to a sell rating in a research note released on Saturday.

Separately, HC Wainwright set a $2.00 price target on IntelGenx Technologies and gave the company a buy rating in a research note on Monday, August 14th.

Shares of IntelGenx Technologies (OTCMKTS:IGXT) opened at $0.71 on Friday. The company has a debt-to-equity ratio of 1.53, a quick ratio of 2.65 and a current ratio of 2.65. IntelGenx Technologies has a 52 week low of $0.62 and a 52 week high of $1.09.

WARNING: “IntelGenx Technologies Corp. (IGXT) Downgraded to Sell at ValuEngine” was first reported by Transcript Daily and is owned by of Transcript Daily. If you are accessing this article on another website, it was copied illegally and reposted in violation of United States and international copyright and trademark law. The original version of this article can be viewed at https://transcriptdaily.com/2017/11/26/intelgenx-technologies-corp-igxt-downgraded-to-sell-at-valuengine.html.

About IntelGenx Technologies

IntelGenx Technologies Corp. is a drug delivery company focusing on the development of orally administered drug delivery products based on its oral drug delivery technologies. The Company is a provider of product development services for the pharmaceutical industry, including the branded and generic pharmaceutical markets.

Receive News & Ratings for IntelGenx Technologies Corp. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for IntelGenx Technologies Corp. and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply